Expression and functional significance of CTLA-4, a negative regulator of T cell activation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 49, Issue 1, 2001, Pages 39-46

  Kosmaczewska, Agata ^a   Ciszak, Lidia ^a   Boćko, Dorota ^a   Frydecka, Irena ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

CTLA 4; Negative regulation; T cell activation

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL; BIOLOGICAL MODEL; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; GENE EXPRESSION; HUMANS; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0035221486     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. BLAIR P. J., RILEY J. L., LEVINE B. L., LEE K. P., CRAIGHEAD N., FRANCOMANO T., PERFETTO S. J., GRAY G. S., CARRENO B. M. and JUNE C. H. (1998): CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction. J. Immunol., 160, 12-15.
2. BLUESTONE J. A. (1997): Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol., 158, 1989-1993.
3. BRADSHAW J., LU P., LEYTZE G., RODGERS J., SCHIEVEN G. L., BENNETT K. L., LINSLEY P. S. and KURTZ S. E. (1997): Interaction of the cytoplasmic tail of CTLA-4 (CD 152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry, 36, 15975-15982.
4. BRUNET J. F., DENIZOT F. and GOLSTEIN P. (1988): A differential molecular biology search for genes preferentially expressed in functional T lymphocytes: the CTLA-4 genes. Immunol. Rev., 103, 21-36.
5. BRUNET J. F., DENIZOT F., LUCIANI M-F., ROUX-DOSSETO M., SUZAN M., MATTEI M.-G and GOLSTEIN P. (1987): A new member of the immunoglobulin superfamily - CTLA-4. Nature, 328, 267-270.
6. CALVO C. R., ANUSEN D. and KRUISBEEK A. M. (1997): Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP-70. J. Exp. Med., 186, 1645-1653.
7. CHAMBERS C. A. and ALLISON J. P. (1996): The role of tyrosine phosphorylation and PTP-1C in CTLA-4 signaling. Eur. J. Immunol., 26, 3224-3229.
8. CHAMBERS C. A., CADO D., TRUONG T. and ALLISON J. P. (1997): Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA, 94, 9296-9301.
9. CHAMBERS C. A., KRUMMEL M. F., BOITEL B., HURWITZ A. A., SULIVA T. J., FOURNIER S., CARSELL D., BRUNNER M. and ALLISON J. P. (1996): The role of CTLA-4 in the regulation and initiation of T cell responses. Immunol. Rev., 153, 27-46.
10. CHUANG E., ALEGRE M. L., DUCKETT C. S., NOEL P. J., VANDER-HEIDEN M. G. and THOMPSON C. B. (1997): Interaction of CTLA-4 with the clathrin-assiciated protein AP-50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol., 159, 144-151.
11. DAMLE N. K., KLUSSMAN K., LEYTZE G., MYRDAL S., ANUFFO A., LEDBETTER J. A. and LINSLEY P. S. (1994): Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J. Immunol., 152, 2686-2697.
12. DARIAVACH P., MATTEI M.-G., GOLSTEIN P. and LEFRANC M.-P. (1988): Human Ig superfamily. CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur. J. Immunol 18, 1901-1905.
13. GOMES N. A., BARRETO-DE-SOUZA V., WILSON M. E. and DOSREIS G. A. (1998): Unresponsive CD4+ T lymphocytes from Leishmania chagasi-infected mice increase cytokine production and mediate parasite killing after blockade of B7/CTLA-4 molecular pathway. J. Infect. Dis., 178, 1847-1851.
14. GRIBBEN J. G., FREEMAN G. J., BOUSIOTTIS V. A., RENNERT P., JELLIS C. L., GREENFIELD E., BARBER M., RESTIVO V. A., KE X., GRAY G. S. and NADLER L. M. (1995): CTLA-4 mediates antigen-specific apoptosis of human T-cells. Proc. Natl. Acad. Aci. USA, 92, 811-815.
15. HARPER K., BALZANO C., ROUVIER E., MATTEI M. G., LUCIANI M. F. and GOLSTEIN P. (1991): CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol., 147, 1037-1044.
16. HUNTER T. (1995): Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell, 80, 225-236.
17. HURWITZ A. A., SULLIVAN T. J., KRUMMEL M. F., SOBEL R. A. and ALLISON J. P. (1997): Specific blockade of CTLA-4/B7 interactions results in exacebated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. J. Neuroimmunol., 73, 57-62.
18. HURWITZ A. A., YU T. F., LEACH D. R. and ALLISON J. P. (1998): CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma. Proc. Natl. Acad. Sci USA, 95, 10067-10071.
19. JENKINS M. K. (1994): The ups and downs of costimulation. Immunity, 1, 443-446.
20. KARANDIKAR N. J., VANDERLUGT C. L., WALUNAS T. L., MILLER S. D. and BLUESTONE J. A. (1996): CTLA-4, a negative regulator of autoimmune disease. J. Exp. Med., 184, 783-788.
21. KRUMMEL M. F. and ALLISON J. P. (1995): CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med., 182, 459-465.
22. KRUMMEL M. F. and ALLISON J. P. (1996): CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med., 183, 2533-2540.
23. KRUMMEL M. F., SULLIVAN T. J. and ALLISON J. P. (1996): Superantigen responses and costimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int. Immunol., 8, 519-523.
24. KWON E. D., HURWITZ A. A., FOSTER B. A., MADIAS C., FELDHAUS A. L., GREENBERG N. M., BURG M. B. and ALLISON J. P. (1997): Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA, 94, 8099-8103.
25. LAFAGE-POCHITALOFF M. R., COSTELLO D., COUEZ J., SIMONETTI D., MANNONI C., MAWAS C. and OLIVE D. (1990): Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics, 31, 198-201.
26. LEACH D. R., KRUMMEL M. F. and ALLISON J. P. (1996): Enchancement of antitumor immunity by CTLA-4 blockade. Science, 271, 1734-1736.
27. LENSCHOW D. J., WALUNAS T. L. and BLUESTONE J. A. (1996): CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol., 14, 233-258.
28. LEUNG H. T., BRADSHAW J., CLEAVELAND J. S. and LINSLEY P. S. (1995): Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem., 270, 1-8.
29. LINDSTEN T., LEE K. P., HARRIS E. S., PETRYNIAK B., CRAIGHEAD N., REYNOLDS P. J., LOMBARD D. B., FREEMAN G. J., NADLER L. M., GRAY G. S., THOMPSON C. B. and JUNE C. H. (1993): Characterization of CTLA-4 structure and expression on human T-cells. J. Immunol., 151, 3489-3499.
30. LINSLEY P. S., BRADSHAW J., GREENE J., PEACH R., BENNET K. L. and MITTLER R. S. (1996): Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity, 4, 535-543.
31. LINSLEY P. S., GREENE J. L., BRADY W., BAJORATH J., LEDBETTER J. A. and PEACH R. (1994): Human B. 7-1 (CD80) and B. 7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity, 1, 793-801.
32. LINSLEY P. S., GREENE J. L., TAN P., BRADSCHAW J., LEDBETTER J. A., ANASETTI C. and DAMLE N. K. (1992): Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med., 176, 1595-1604.
33. LINSLEY P. S. and LEDBETTER J. A. (1993): The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol., 11, 191-212.
34. LINSLEY P. S., NADLER S. G., BAJORATH J., PEACH R., LEUNG H. T., ROGERS J., BRADSHAW J., STEBBINS M., LEYTZE G. and BRADY W. (1995): Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). J. Biol. Chem., 270, 15417-15424.
35. MARENGERE L. E. M., WATERHOUSE P., DUNCAN G. S., MITTRUCKER H.-W., FENG G. S. and MAK T. W. (1996): Regulation of T cell receptor signaling by tyrosine-phosphatase Syp association with CTLA-4. Science, 272, 1170-1173.
36. MARSHAL C. J. (1995): Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80, 179-185.
37. MCCOY K., CAMBIRES M. and GROS G. L. (1997): Protective immunity to nematode infection is induced by CTLA-4 blockade. J. Exp. Med., 186, 183-187.
38. MIYATAKE S., NAKASEKO C., UMEMORI H., YAMAMOTO T. and SAITO T. (1998): Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152). Biochem. Biophys. Res. Commun., 249, 444-448.
39. MORTON P. A., FU X-T., STEWART J. A., GIACOLETTO K. S., WHITE S. L., LEYSATH S. E., EVANS R. J., SHIEH J.-J. and KARR R. W. (1996): Differential effects of CTLA-4 substitutions on the binding of human CD80 (B. 7-1) and CD86 (B. 7-2). J. Immunol., 156, 1047-1054.
40. PAWSON T. (1995): Protein modules and signalling networks. Nature, 373, 573-580.
41. PEACH R. J., BAJORATH J., BRADY W., LEYTZE G., GREENE J., NAEMURA J. and LINSLEY P. S. (1994): Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine binding to B. 7-1. J. Exp. Med., 180, 2049-2058.
42. PEREZ V. L., VAN PARUS L., BIUCKIANS A., ZHENG X. X., STROM T. B. and ABBAS A. K. (1997): Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagements. Immunity, 6, 411-417.
43. PERKINS D., NANG Z., DONOVAN C., HE H., MARK D., GUAN G., WANG Y., WALUNAS T., BLUESTONE J. and LISTMAN J. (1996): Regulation of CTLA-4 expression during T cell activation. J. Immunol., 156, 4154-4159.
44. SAMOILOVA E. B., HORTON J. L., ZHANG H., KHOURY S. J., WEINER H. L. and CHEN Y. (1998): CTLA-4 is required for the induction of high dose oral tolerance. Int. Immunol., 10, 491-498.
45. SCHEIPERS P. and REISER H. (1998): Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 cross-linking. Proc. Natl. Acad. Sci. USA, 95, 10083-10088.
46. SHIRATORI T., MIYATAKE S., OHNO H., NAKASEKO C., ISONO K., BONIFACINO J. S. and SAITO T. (1997): Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity, 6, 583-589.
47. SONGYANG Z., SHOELSON S. E., CHAUDHURI M., GISH G., PAWSON T., NASER W. G., KING F., ROBERTS T., RATNOFSKY S., LECHLEIDER R. J., NEEL B. G., BIRGE R. B., FAJARDO J. E., CHOU M. M., HANAFUSA H., SCHAFFHAUSEN B. and CANTLEY L. C. (1993): SH2 domains recognize specific phosphopeptide sequences. Cell, 72, 767-778.
48. SU B., JACINTO E., HIBI M., KALLUNKI T., KARIN M. and BEN-NERIACH Y. (1994): JNK is involved in signal integration during costimulation of T lymphocytes. Cell, 77, 727-736.
49. TIVOL E. A., BOYD S. D., MCKEON S., BORRIELLO F., NICKERSON P., STROM T. B. and SHARPE A. H. (1997): CTLA-4 Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol., 158, 5091-5094.
50. WALUNAS T. L., BAKKER C. Y. and BLUESTONE J. A. (1996): CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med., 183, 2541-2550.
51. WALUNAS T. L. and BLUESTONE J. A. (1998): CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol., 160, 3855-3860.
52. WALUNAS T. L., LENSHOW D. J., BAKKER C. Y., LINSLEY P. S., FREEMAN G. J., GREEN J. M., THOMPSON C. B. and BLUESTONE J. A. (1994): CTLA-4 can function as a negative regulator of T cell activation, Immunity, 1, 405-413.
53. WATERHOUSE P., MARENGERE L. E. M., MITTRUCKER H. W. and MAK T. W. (1996): CTLA-4, a negative regulator of T lymphocyte activation. Immunol. Rev., 153, 183-207.
54. WATERHOUSE P., PENNINGER J. M., TIMMS E., WAKEHAM A., SHAHINIAN A., LEE K. P., THOMPSON C. B., GRIESSER H. and MAK T. W. (1995): Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science, 270, 985-988.
55. YANG Y. F., ZOU J. P., MU J., WIJESURIYA R., ONO S., WALUNAS T., BLUESTONE J., FUJIWARA H. and HAMAOKA T. (1997): Enhanced induction of antitumor T-cell responses by cytotoxic T-lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages. Cancer Res., 57, 4036-4041.
56. ZHANG Y. and ALLISON J. P. (1997): Interaction of CTLA-4 with AP-50, a clathrin-coated pit adaptor protein. Proc. Natl. Acad. Sci. USA, 94, 9273-9278.